HES1 and acute lymphoblastic leukemia: In this study, the NOTCH pathway was affected in about 60% of all T-ALL patients (Figure 1B), including mutations in NOTCH1 and FBXW7 as well as in NOTCH2, NOTCH3, HES1, JAG1, and JAG2 (Supplementary Table S3).